Results 41 to 50 of about 147 (124)

Outcome of surgical resection in Klatskin tumors

open access: yesWorld Journal of Gastrointestinal Oncology, 2013
Cholangiocarcinomas are the second most frequent primary hepatic malignancy, and make up from 5% to 30% of malignant hepatic tumours. Hilar cholangiocarcinoma (HCC) is the most common type, and accounts for approximately 60% to 67% of all cholangiocarcinoma cases.
Alejandro, Serrablo, Luis, Tejedor
openaire   +2 more sources

The Klatskin Tumor That Wasn't: An Unusual Presentation of Sarcoidosis

open access: yesACG Case Reports Journal, 2016
We present the case of a patient who presented with signs and symptoms associated with a Klatskin tumor. After endoscopic retrograde cholangiopancreatography (ERCP) and biopsy, she was found instead to have granulomatous infiltration of the extrahepatic biliary tree consistent with biliary sarcoidosis. The patient was treated successfully with systemic
Farooq, Priya D., Potosky, Darryn R.
openaire   +2 more sources

Endoscopic Biliary Darinage (EBD) versus Percutaneous Transhepatic Biliary Drainage (PTBD) for biliary drainage in patients with Perihilar Cholangiocarcinoma (PCCA): A systematic review and meta-analysis. [PDF]

open access: yesClinics (Sao Paulo), 2023
Moll CF   +9 more
europepmc   +1 more source

Klatskin Tumor – Results of Surgical Therapy

open access: yesCollegium antropologicum, 2005
Between January 1st 1990 and December 31st 1999, 24 patients affected by Klatskin tumor underwent operation in our department of surgery. According to Bismuth's classification, there were 0 (0%) type I, 5 (21%) type II, 6 (25%) type IIIa, 4 (17%) type IIIb and 9 (37%) type IV tumors.
Zovak, Mario   +5 more
openaire   +4 more sources

UEG Week 2024 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 12, Issue S8, Page 665-1360, October 2024.
wiley   +1 more source

Irreversible Electroporation for Perihilar Cholangiocarcinoma (Klatskin Tumors)

open access: yes, 2017
The overall prognosis for patients with perihilar cholangiocarcinoma (PHC) is dismal. Resection of the tumor remains the only curative treatment, but only 10–20% of patients have resectable disease at the time of diagnosis [1]. The majority of patients present with locally advanced disease or lymph node metastases upon presentation or during ...
Roos, Eva   +5 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy